FDA NDC Directory · JSON-LD · Markdown

Sulfasalazine

NDC 11534-200 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerSunrise Pharmaceutical, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA040349
Dosage form / routeTABLET · ORAL
Active ingredientsSULFASALAZINE (500 mg/1)
Marketing started20250715
Package count3

External sources

Source: openFDA. Public-domain (CC0).